Trials / Completed
CompletedNCT03576716
Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to determine how 25(OH)D3 clearance is affected by vitamin D3 supplementation using a gold standard pharmacokinetic approach.
Detailed description
We expect that this study will enhance interpretation of available diagnostic tests, inform the results of ongoing large clinical trials of vitamin D supplements, and help develop new strategies to target vitamin D to improve health.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D6-25-hydroxyvitamin D3 | Intravenous administration of a deuterium-labeled 25(OH)D3 to evaluate the metabolic clearance of 25(OH)D3 |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2019-07-08
- Completion
- 2021-01-01
- First posted
- 2018-07-03
- Last updated
- 2022-05-17
- Results posted
- 2021-09-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03576716. Inclusion in this directory is not an endorsement.